Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with chronic migraine eligible to receive treatment with onabotulinumtoxinA (BOTOX®) as standard of care.
You may not be if
Diagnosis of hemiplegic migraine, basilar migraine, ophthalmoplegic migraine or migrainous infarction, chronic tension-type headache, hypnic headache, hemicrania continua or new daily persistent headache.
Patient who is currently taking or planning on taking opioid-containing products, barbiturates or combination for acute headache or pain condition.
Treatment with any other botulinum toxin product for any condition within 3 months of the screening visit.
Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis or any other significant disease that might interfere with neuromuscular function.
Clareo Health | Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®
